[Federal Register Volume 79, Number 177 (Friday, September 12, 2014)]
[Notices]
[Page 54729]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-21728]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2013-N-1422]
Agency Information Collection Activities; Announcement of Office
of Management and Budget Approval; Eye Tracking Study of Direct-to-
Consumer Prescription Drug Advertisement Viewing
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
collection of information entitled ``Eye Tracking Study of Direct-to-
Consumer Prescription Drug Advertisement Viewing'' has been approved by
the Office of Management and Budget (OMB) under the Paperwork Reduction
Act of 1995.
FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations,
Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver
Spring, MD 20993-0002, [email protected].
SUPPLEMENTARY INFORMATION: On June 30, 2014, the Agency submitted a
proposed collection of information entitled ``Eye Tracking Study of
Direct-to-Consumer Prescription Drug Advertisement Viewing'' to OMB for
review and clearance under 44 U.S.C. 3507. An Agency may not conduct or
sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB control number.
OMB has now approved the information collection and has assigned OMB
control number 0910-0772. The approval expires on August 31, 2017. A
copy of the supporting statement for this information collection is
available on the Internet at http://www.reginfo.gov/public/do/PRAMain.
Dated: September 8, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014-21728 Filed 9-11-14; 8:45 am]
BILLING CODE 4164-01-P